Adverse long-term effects of reocclusion after coronary thrombolysis

This publication has 25 references indexed in Scilit:

• Does PTCA in Acute Myocardial Infarction Affect Mortality and Reinfarction Rates?
  Circulation, 1995
• Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: Effects of antiplatelet therapy
  Journal of the American College of Cardiology, 1995
• Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling.
  Circulation, 1994
• Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group.
  Circulation, 1994
• A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial
  Journal of the American College of Cardiology, 1994
• Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.
  Circulation, 1993
• A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial Infarction
  New England Journal of Medicine, 1990
• Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
  Circulation, 1990
• Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands
  Journal of the American College of Cardiology, 1989
• Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
  Circulation, 1987